ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,698Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 1844

$1.16M Total Retail Price of All Prescriptions

Rank: 28 out of 1844

889 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 889 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

27% of this provider’s 889 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 17,004 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 1,025 505 S3 1 2
LEVOTHYROXINE SODIUM 704 582 2 1
LISINOPRIL 663 462 3 4
FUROSEMIDE 657 572 4 7
AMLODIPINE BESYLATE 635 559 5 6
SIMVASTATIN 628 469 6 3
POTASSIUM CHLORIDE 574 488 7 16
WARFARIN SODIUM 568 483 8 13
OMEPRAZOLE 498 380 9 5
AZITHROMYCIN 403 273 10 37
METOPROLOL SUCCINATE 384 339 11 14
GABAPENTIN 383 252 12 15
METFORMIN HCL 335 195 13 8
HYDROCHLOROTHIAZIDE 274 216 14 9
GLIMEPIRIDE 270 200 15 35
PREDNISONE 242 186 16 40
SERTRALINE HCL 239 161 17 21
METOPROLOL TARTRATE 225 171 18 11
ZOLPIDEM TARTRATE 216 106 19 23
OXYCODONE HCL-ACETAMINOPHEN 211 44 S2 20 83
METHADONE HCL 208 71 S2 21 133
CITALOPRAM HBR 207 137 22 19
CARVEDILOL 200 159 23 22
ATENOLOL 192 113 24 17
ATORVASTATIN CALCIUM 184 128 25 12
TRAMADOL HCL 175 118 26 18
TAMSULOSIN HCL 174 130 27 27
ALLOPURINOL 173 153 28 29
DOXYCYCLINE HYCLATE 168 130 29 90
FENOFIBRATE 165 106 30 71
DONEPEZIL HCL 155 154 31 26
ALENDRONATE SODIUM 152 132 32 25
PROAIR HFA 151 59 33 45
PANTOPRAZOLE SODIUM 149 95 34 32
CRESTOR 145 120 35 30
SPIRONOLACTONE 140 110 36 60
MELOXICAM 139 107 37 28
NEXIUM 138 117 38 31
AMITRIPTYLINE HCL 132 91 R 39 72
LOSARTAN-HYDROCHLOROTHIAZIDE 130 129 40 47
LISINOPRIL-HYDROCHLOROTHIAZIDE 128 107 41 20
LOSARTAN POTASSIUM 127 104 42 24
FENTANYL 125 81 S2 43 66
RISPERIDONE 124 110 44 65
LEVOFLOXACIN 120 89 45 78
PRAVASTATIN SODIUM 120 87 45 10
GLYBURIDE 117 86 R 47 100
NAMENDA 115 115 48 33
POLYETHYLENE GLYCOL 3350 114 85 49 39
KLOR-CON M20 114 100 49 54
KLOR-CON 10 112 75 51 123
ESTRADIOL 112 69 R 51 181
TRAZODONE HCL 111 45 53 43
OXYBUTYNIN CHLORIDE 107 89 54 103
TRIAMTERENE-HCTZ 106 65 55 48
METHYLPREDNISOLONE 105 77 56 125
AMOX TR-POTASSIUM CLAVULANATE 104 66 57 139
PROBENECID-COLCHICINE 101 73 10 58 378
LEVEMIR FLEXPEN 100 74 59 166
CLINDAMYCIN HCL 99 66 60 325
ACTOS 99 77 60 130
SPIRIVA 96 46 62 57
ISOSORBIDE MONONITRATE ER 96 87 62 59
FLUOXETINE HCL 96 60 62 41
CLOPIDOGREL 95 85 65 34
ALBUTEROL SULFATE 95 93 65 115
TORSEMIDE 94 68 67 118
METOLAZONE 93 79 68 209
BISOPROLOL-HYDROCHLOROTHIAZIDE 93 71 68 99
DIGOXIN 88 85 70 67
KLOR-CON M10 87 73 71 149
RANITIDINE HCL 87 69 71 38
FLUOCINONIDE 85 63 73 257
BACLOFEN 82 33 74 119
PLAVIX 81 66 75 61
COUMADIN 81 40 75 175
PAROXETINE HCL 80 48 77 68
OXYCODONE-ACETAMINOPHEN 80 49 S2 77 94
VENLAFAXINE HCL ER 80 36 77 93
PROPRANOLOL HCL 79 69 80 129
CEPHALEXIN 78 55 81 56
CLONIDINE HCL 77 69 82 64
ESCITALOPRAM OXALATE 77 63 82 52
JANUVIA 75 66 84 77
TERAZOSIN HCL 73 60 85 136
CYCLOBENZAPRINE HCL 72 25 R 86 53
SULFAMETHOXAZOLE-TRIMETHOPRIM 71 53 87 73
MORPHINE SULFATE ER 70 21 S2 88 107
NOVOLOG FLEXPEN 63 47 89 163
ADVAIR DISKUS 62 38 90 51
ROPINIROLE HCL 62 48 90 76
BUPROPION HCL 61 43 92 317
LANTUS 59 55 93 42
PREMARIN 58 40 R 94 171
DICYCLOMINE HCL 58 53 94 197
LYRICA 58 47 94 92
BENICAR 58 48 94 218
INSULIN SYRINGE 57 20 98 111
GLIPIZIDE 57 55 98 70
NITROSTAT 56 40 100 261
DIOVAN HCT 56 27 100 96
AVODART 55 55 102 219
GEMFIBROZIL 55 47 102 108
CIPROFLOXACIN HCL 54 45 104 62
OXYBUTYNIN CHLORIDE ER 54 49 104 126
NYSTATIN-TRIAMCINOLONE 54 47 104 252
HYDROMORPHONE HCL 53 13 S2 107 269
BENAZEPRIL HCL 53 34 107 75
SINGULAIR 53 42 107 102
CYMBALTA 53 17 107 36
FINASTERIDE 53 53 107 137
TRICOR 52 30 112 109
PEN NEEDLE 52 31 112 135
LANSOPRAZOLE 52 24 112 194
AMIODARONE HCL 52 52 112 208
PROMETHAZINE HCL 52 30 R 112 88
TRILIPIX 51 28 117 167
DIOVAN 51 41 117 58
HUMULIN N 51 51 117 234
PIOGLITAZONE HCL 51 41 R 117 327
IPRATROPIUM BROMIDE 50 50 121 198
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 23, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.